To be frank though, I thought fairly obvious in original announcement (re 76% of participants at 100% eradication). The % success rate not being divisible by 22 is a bit of a technicality and not really a problem unless you’re looking for a flaw (though easily explained nonetheless).
I agree that the Argonaut valuation seems conservative on a couple of fronts (both in acne valuation as Jonotron points out) and in applying a generic probability of trial success when safety profile arguably improves this probability significantly.
- Forums
- ASX - By Stock
- BOT
- BOT - Anything but charting
BOT - Anything but charting, page-1803
-
-
- There are more pages in this discussion • 9,073 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
LU7
Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries
Add BOT (ASX) to my watchlist
(20min delay)
|
|||||
Last
37.0¢ |
Change
-0.010(2.63%) |
Mkt cap ! $671.1M |
Open | High | Low | Value | Volume |
38.0¢ | 38.0¢ | 37.0¢ | $1.949M | 5.207M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 163455 | 37.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
37.5¢ | 33207 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 130837 | 0.370 |
10 | 99517 | 0.365 |
16 | 271384 | 0.360 |
7 | 220353 | 0.355 |
26 | 1051912 | 0.350 |
Price($) | Vol. | No. |
---|---|---|
0.380 | 44778 | 1 |
0.385 | 245000 | 3 |
0.390 | 10960 | 1 |
0.395 | 123443 | 3 |
0.400 | 179748 | 4 |
Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
Featured News
BOT (ASX) Chart |